DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @kevstar044 | 17 |
| @ThisLincolnian | 15 |
| @Gambiste1 | 14 |
| @TickerReport | 14 |
| @AmericanBanking | 14 |
Recent Tweets for EXEL
 |
@WeekHerald Exelixis $EXEL Upgraded by BidaskClub to “Hold” https://t.co/AdwfN6xdIq 5:01pm |
 |
@dakotafinancial Exelixis $EXEL Raised to “Hold” at BidaskClub https://t.co/y29Imppcdh 5:01pm |
 |
@biotechw2019 $EXEL watch for a long lower wick close or red to green ? 2:01pm |
 |
@kevstar044 RT @biotechw2019: $EXEL 50 crossed 100 DMA ! https://t.co/3Q8qFuKORb 2:01pm |
|
@kevstar044 @biotechw2019 Game on. Big data coming tomorrow. Added every dip. $EXEL 2:01pm |
|
@biotechw2019 $EXEL 50 crossed 100 DMA ! https://t.co/3Q8qFuKORb 2:01pm |
 |
@TickerReport Exelixis, Inc. $EXEL CEO Sells $508,250.00 in Stock https://t.co/tazLYRoCR0 4:01am |
 |
@ThisLincolnian Exelixis, Inc. $EXEL CEO Sells $508,250.00 in Stock https://t.co/ENBSBwrzMS 4:01am |
 |
@EnterpriseLeade Insider Selling: Exelixis, Inc. $EXEL Director Sells $1,234,276.83 in Stock https://t.co/6piGzozY59 4:01am |
 |
@Gambiste1 RT @StckPro: $EXEL NEW ARTICLE : Exelixis: Looking Good, Despite Stagnant Product Sales Guidance https://t.co/zsuYNywGbS Get all the latest… 2:01am |
 |
@StckPro $EXEL NEW ARTICLE : Exelixis: Looking Good, Despite Stagnant Product Sales Guidance https://t.co/zsuYNywGbS Get all… https://t.co/iOsVPL0TVD 12:01am |
 |
@SeekingAlpha $EXEL - Exelixis: Looking Good, Despite Stagnant Product Sales Guidance. https://t.co/nCK6EMqoab #stockmarket #finance #investing 12:01am |
 |
@TranscriptDaily Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.17 Per Share https://t.co/J1kPjzFluJ 12:01am |
 |
@rajsanghera559 On 1-16 I bot 2 $EXEL may15 25c in 1.15 sold today out .70 red? January 22nd 2020, 3:01pm |
|
@StckPro $EXEL NEW ARTICLE : Can Investors Excel in 2020 With Exelixis? https://t.co/cCbK9YRG23 Get all the latest $EXEL rel… https://t.co/tcLFc0XIAF January 22nd 2020, 2:01pm |
|
@kevstar044 RT @biotechw2019: $EXEL inside day ! 50 poised to cross 100 DMA https://t.co/wZbcGDSt8e January 22nd 2020, 12:01pm |
|
@biotechw2019 $EXEL inside day ! 50 poised to cross 100 DMA https://t.co/wZbcGDSt8e January 22nd 2020, 12:01pm |
 |
@stocknewstimes Exelixis $EXEL Stock Rating Upgraded by BidaskClub https://t.co/7ktDVI4lTN January 22nd 2020, 6:01am |
 |
@ZolmaxNews Vincent T. Marchesi Sells 61,683 Shares of Exelixis, Inc. $EXEL Stock https://t.co/PuJCHYRv6j January 22nd 2020, 4:01am |
 |
@realmaciej RT @semodough: Baml $EXEL Tonight's Ph1/2 CM040 abstract provides a preview of IO/cabo efficacy in HCC ahead of Ph3 COSMIC-312 (2H'20). don… January 21st 2020, 10:01pm |
 |
@semodough Baml $EXEL Tonight's Ph1/2 CM040 abstract provides a preview of IO/cabo efficacy in HCC ahead of Ph3 COSMIC-312 (2H… https://t.co/GB34EUttgf January 21st 2020, 9:01pm |
|
@kevstar044 RT @WatchlistN: Brokerages Set Exelixis, Inc. $EXEL Target Price at $25.40 https://t.co/0su3BXzOrP January 21st 2020, 4:01pm |
 |
@dispatchtribune Brokerages Set Exelixis, Inc. $EXEL Price Target at $25.40 https://t.co/Bfg4jsvDU1 January 21st 2020, 4:01pm |
 |
@WatchlistN Brokerages Set Exelixis, Inc. $EXEL Target Price at $25.40 https://t.co/0su3BXzOrP January 21st 2020, 4:01pm |
 |
@JorelLaraKalel Exelixis: What's Ahead For 2020 $EXEL https://t.co/h4bZkgMc2h January 21st 2020, 4:01pm |
|
@kevstar044 $EXEL weak hands out. Strong hands holding, something big about to go down. Got the blood flowing. https://t.co/jfvCkNiZ03 January 21st 2020, 2:01pm |
 |
@bret_jensen Commented on $EXEL - Exelixis:?sht=q4gx7i&shu=aozs What's Ahead For 2020. https://t.co/r1crfdq5HC January 21st 2020, 12:01pm |
|
@kevstar044 $EXEL something's about to go down. ????????. 2020 the year January 21st 2020, 11:01am |
|
@ZolmaxNews Exelixis, Inc. $EXEL CEO Michael Morrissey Sells 25,000 Shares https://t.co/2KXexsfk7L January 21st 2020, 4:01am |
|
@TickerReport Insider Selling: Exelixis, Inc. $EXEL Director Sells 61,683 Shares of Stock https://t.co/Zd3bzvhXZ0 January 21st 2020, 4:01am |
|
@ThisLincolnian Exelixis, Inc. $EXEL Director Vincent T. Marchesi Sells 61,683 Shares of Stock https://t.co/FR6LsTW8WZ January 21st 2020, 4:01am |
 |
@Tickeron 3 Insiders at Exelixis sold 111,683 shares last week for $2.3M $EXEL #Exelixis #stockmarket #stock #money #trading… https://t.co/VwA7HeS5xj January 21st 2020, 3:01am |
 |
@DuarteSatirico RT @semodough: $EXEL Cabometyx's overall share in renal cancer has fallen from ~21% to 14% insecond half of 2019 due to increased competiti… January 20th 2020, 7:01pm |
|
@semodough $EXEL Cabometyx's overall share in renal cancer has fallen from ~21% to 14% insecond half of 2019 due to increased… https://t.co/LL4Xw9VU4Z January 20th 2020, 4:01pm |
 |
@SwingTradeBot Recent $EXEL technical alerts: Stochastic Sell Signal plus 5 more alerts... https://t.co/R8mMMMOolt January 20th 2020, 3:01pm |
|
@dakotafinancial Insider Selling: Exelixis, Inc. $EXEL Director Sells 61,683 Shares of Stock https://t.co/m5i4RjVGZo January 20th 2020, 2:01pm |
 |
@AmericanBanking Insider Selling: Exelixis, Inc. $EXEL Director Sells 61,683 Shares of Stock https://t.co/wf0oCLPgJ6 #stocks January 20th 2020, 2:01pm |
|
@AmericanBanking Exelixis, Inc. $EXEL CEO Sells $508,250.00 in Stock https://t.co/YMKLABT28k #stocks January 20th 2020, 2:01pm |
|
@WeekHerald Insider Selling: Exelixis, Inc. $EXEL Director Sells 61,683 Shares of Stock https://t.co/5yRR1gN4tI January 20th 2020, 2:01pm |
|
@TranscriptDaily Exelixis, Inc. $EXEL CEO Sells $508,250.00 in Stock https://t.co/g7SLWQnePG January 20th 2020, 2:01pm |
|
@WeekHerald Zacks: Brokerages Anticipate Exelixis, Inc. $EXEL Will Announce Earnings of $0.17 Per Share https://t.co/yqHrnudWQf January 20th 2020, 9:01am |
|
@dakotafinancial Exelixis, Inc. $EXEL Expected to Announce Earnings of $0.17 Per Share https://t.co/ksHZ9uwSx0 January 20th 2020, 9:01am |
|
@ThisLincolnian Exelixis $EXEL Upgraded by BidaskClub to Sell https://t.co/IKh8USlUeA January 20th 2020, 1:01am |
|
@Gambiste1 RT @bret_jensen: Commented on $EXEL - Exelixis:?sht=q4dwny&shu=aozs What's Ahead For 2020. https://t.co/7d8JHhBX3P January 20th 2020, 1:01am |
 |
@gcassidy718 $EXEL what a Company -3.03 % change recently https://t.co/yJURATPF4w January 20th 2020, 12:01am |
|
@bret_jensen Commented on $EXEL - Exelixis:?sht=q4dwny&shu=aozs What's Ahead For 2020. https://t.co/7d8JHhBX3P January 19th 2020, 9:01pm |
 |
@BigChodu Needless to tell my friends that $exel is strong sell now ???????? https://t.co/szLo3C6YZa January 19th 2020, 5:01pm |
|
@Gambiste1 RT @bret_jensen: Commented on $EXEL - Exelixis:?sht=q4ddoj&shu=aozs What's Ahead For 2020. https://t.co/IhUwuaeJ9s January 19th 2020, 3:01pm |
|
@Gambiste1 RT @bret_jensen: Commented on $EXEL - Exelixis:?sht=q4ddnd&shu=aozs What's Ahead For 2020. https://t.co/cTIz95IUET January 19th 2020, 3:01pm |
|
@bret_jensen Commented on $EXEL - Exelixis:?sht=q4ddoj&shu=aozs What's Ahead For 2020. https://t.co/IhUwuaeJ9s January 19th 2020, 2:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.